Annual Working Capital
$114.39 M
+$1.94 M+1.73%
31 December 2023
Summary:
Black Diamond Therapeutics annual working capital is currently $114.39 million, with the most recent change of +$1.94 million (+1.73%) on 31 December 2023. During the last 3 years, it has fallen by -$190.95 million (-62.54%). BDTX annual working capital is now -62.54% below its all-time high of $305.34 million, reached on 31 December 2020.BDTX Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$94.74 M
-$13.58 M-12.53%
30 September 2024
Summary:
Black Diamond Therapeutics quarterly working capital is currently $94.74 million, with the most recent change of -$13.58 million (-12.53%) on 30 September 2024. Over the past year, it has dropped by -$37.24 million (-28.22%). BDTX quarterly working capital is now -73.30% below its all-time high of $354.79 million, reached on 31 March 2020.BDTX Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDTX Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.7% | -28.2% |
| 3 y3 years | -62.5% | -56.0% |
| 5 y5 years | +132.9% | +27.5% |
BDTX Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -62.5% | +1.7% | -56.0% | +19.8% |
| 5 y | 5 years | -62.5% | +132.9% | -73.3% | +27.5% |
| alltime | all time | -62.5% | +1912.5% | -73.3% | +92.9% |
Black Diamond Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $94.74 M(-12.5%) |
| June 2024 | - | $108.31 M(+6.2%) |
| Mar 2024 | - | $101.95 M(-10.9%) |
| Dec 2023 | $114.39 M(+1.7%) | $114.39 M(-13.3%) |
| Sept 2023 | - | $131.98 M(+66.9%) |
| June 2023 | - | $79.09 M(-16.9%) |
| Mar 2023 | - | $95.13 M(-15.4%) |
| Dec 2022 | $112.44 M(-41.5%) | $112.44 M(-13.4%) |
| Sept 2022 | - | $129.84 M(-12.8%) |
| June 2022 | - | $148.85 M(-11.8%) |
| Mar 2022 | - | $168.84 M(-12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $192.06 M(-37.1%) | $192.06 M(-10.7%) |
| Sept 2021 | - | $215.19 M(-13.0%) |
| June 2021 | - | $247.46 M(-11.2%) |
| Mar 2021 | - | $278.64 M(-8.7%) |
| Dec 2020 | $305.34 M(+102.4%) | $305.34 M(-6.1%) |
| Sept 2020 | - | $325.09 M(+60.8%) |
| June 2020 | - | $202.11 M(-43.0%) |
| Mar 2020 | - | $354.79 M(+135.2%) |
| Dec 2019 | $150.85 M(+207.2%) | $150.85 M(+103.0%) |
| Sept 2019 | - | $74.31 M(+51.3%) |
| Dec 2018 | $49.11 M(+764.0%) | $49.11 M |
| Dec 2017 | $5.68 M | - |
FAQ
- What is Black Diamond Therapeutics annual working capital?
- What is the all time high annual working capital for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics annual working capital year-on-year change?
- What is Black Diamond Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Black Diamond Therapeutics?
- What is Black Diamond Therapeutics quarterly working capital year-on-year change?
What is Black Diamond Therapeutics annual working capital?
The current annual working capital of BDTX is $114.39 M
What is the all time high annual working capital for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high annual working capital is $305.34 M
What is Black Diamond Therapeutics annual working capital year-on-year change?
Over the past year, BDTX annual working capital has changed by +$1.94 M (+1.73%)
What is Black Diamond Therapeutics quarterly working capital?
The current quarterly working capital of BDTX is $94.74 M
What is the all time high quarterly working capital for Black Diamond Therapeutics?
Black Diamond Therapeutics all-time high quarterly working capital is $354.79 M
What is Black Diamond Therapeutics quarterly working capital year-on-year change?
Over the past year, BDTX quarterly working capital has changed by -$37.24 M (-28.22%)